Request a Quotation

Your Contact Information
Peptides Logo
Support and counselling under:
+49(0)3302 - 2022000 info@peptides.de
€0.00*

peptides&elephants receives ProFIT funding for MHC Class I Peptide Pool launch

Dr. Oliver Kreuzer beside the ProFIT funding certificate

peptides&elephants has received funding through Brandenburg’s ProFIT Innovation Program, co-financed by the European Regional Development Fund (EFRE) and the State of Brandenburg.

The project “Market Launch: Establishment of a New Peptide Product Family – Introduction of Novel MHC Class I Peptide Pools” supports the development of a next-generation MHC Class I Peptide Pool product line. These peptide tools will advance immunological research by enabling more precise studies of T cell responses and antigen presentation.

With ProFIT support, peptides&elephants will:

  • Launch innovative MHC Class I Peptide Pools
  • Expand peptide synthesis and purification at the Hennigsdorf site
  • Strengthen collaborations within Brandenburg’s biotech ecosystem

This project bridges peptide chemistry and translational immunology — helping to accelerate discoveries in infectious disease and cancer research.

About p&e

Our Mission is to provide high quality peptides quickly and efficiently, to ensure complete customer satisfaction. We are a dedicated team of highly qualified individuals ready to address your most challenging peptide requirements. By developing our peptide synthesis robots in-house, we have full control over the manufacturing process.

This means we can assure highest quality and respond quickly and flexibly to all research requirements. To achieve this, we draw on over 23 years of experience in peptide synthesis and robot development.

Subscribe to newsletter
Privacy*
Fields marked with asterisks (*) are required.
This website uses cookies to ensure the best experience possible. More information...